(Newser) -
Pfizer will shell out $2.3 billion—a record for a health care fraud settlement—over deceptive marketing of its drugs, the
Los Angeles Times reports. Pfizer and one of its subsidiaries marketed four drugs based on off-label uses specifically prohibited by the FDA. The settlement with the Justice Department...
More »
